| Title : Future perspectives for insulinotropic agents in the treatment of type 2 diabetes-DPP-4 inhibitors and sulphonylureas - Gallwitz_2010_Diabetes.Obes.Metab_12_1 |
| Author(s) : Gallwitz B , Haring HU |
| Ref : Diabetes Obes Metab , 12 :1 , 2010 |
| Abstract : |
| PubMedSearch : Gallwitz_2010_Diabetes.Obes.Metab_12_1 |
| PubMedID: 19788431 |
| Title : Future perspectives for insulinotropic agents in the treatment of type 2 diabetes-DPP-4 inhibitors and sulphonylureas - Gallwitz_2010_Diabetes.Obes.Metab_12_1 |
| Author(s) : Gallwitz B , Haring HU |
| Ref : Diabetes Obes Metab , 12 :1 , 2010 |
| Abstract : |
| PubMedSearch : Gallwitz_2010_Diabetes.Obes.Metab_12_1 |
| PubMedID: 19788431 |
| Title : Future perspectives for insulinotropic agents in the treatment of type 2 diabetes-DPP-4 inhibitors and sulphonylureas - Gallwitz_2010_Diabetes.Obes.Metab_12_1 |
| Author(s) : Gallwitz B , Haring HU |
| Ref : Diabetes Obes Metab , 12 :1 , 2010 |
| Abstract : |
| PubMedSearch : Gallwitz_2010_Diabetes.Obes.Metab_12_1 |
| PubMedID: 19788431 |
| Title : Preclinical and Clinical Data on Extraglycemic Effects of GLP-1 Receptor Agonists - Gallwitz_2009_Rev.Diabet.Stud_6_247 |
| Author(s) : Gallwitz B |
| Ref : Rev Diabet Stud , 6 :247 , 2009 |
| Abstract : |
| PubMedSearch : Gallwitz_2009_Rev.Diabet.Stud_6_247 |
| PubMedID: 20043037 |
| Title : Mechanism of action of inhibitors of dipeptidyl-peptidase-4 (DPP-4) - Thornberry_2009_Best.Pract.Res.Clin.Endocrinol.Metab_23_479 |
| Author(s) : Thornberry NA , Gallwitz B |
| Ref : Best Pract Res Clinical Endocrinology Metab , 23 :479 , 2009 |
| Abstract : |
| PubMedSearch : Thornberry_2009_Best.Pract.Res.Clin.Endocrinol.Metab_23_479 |
| PubMedID: 19748065 |
| Title : Mechanism of action of inhibitors of dipeptidyl-peptidase-4 (DPP-4) - Thornberry_2009_Best.Pract.Res.Clin.Endocrinol.Metab_23_479 |
| Author(s) : Thornberry NA , Gallwitz B |
| Ref : Best Pract Res Clinical Endocrinology Metab , 23 :479 , 2009 |
| Abstract : |
| PubMedSearch : Thornberry_2009_Best.Pract.Res.Clin.Endocrinol.Metab_23_479 |
| PubMedID: 19748065 |
| Title : Preclinical and Clinical Data on Extraglycemic Effects of GLP-1 Receptor Agonists - Gallwitz_2009_Rev.Diabet.Stud_6_247 |
| Author(s) : Gallwitz B |
| Ref : Rev Diabet Stud , 6 :247 , 2009 |
| Abstract : |
| PubMedSearch : Gallwitz_2009_Rev.Diabet.Stud_6_247 |
| PubMedID: 20043037 |
| Title : Mechanism of action of inhibitors of dipeptidyl-peptidase-4 (DPP-4) - Thornberry_2009_Best.Pract.Res.Clin.Endocrinol.Metab_23_479 |
| Author(s) : Thornberry NA , Gallwitz B |
| Ref : Best Pract Res Clinical Endocrinology Metab , 23 :479 , 2009 |
| Abstract : |
| PubMedSearch : Thornberry_2009_Best.Pract.Res.Clin.Endocrinol.Metab_23_479 |
| PubMedID: 19748065 |
| Title : Preclinical and Clinical Data on Extraglycemic Effects of GLP-1 Receptor Agonists - Gallwitz_2009_Rev.Diabet.Stud_6_247 |
| Author(s) : Gallwitz B |
| Ref : Rev Diabet Stud , 6 :247 , 2009 |
| Abstract : |
| PubMedSearch : Gallwitz_2009_Rev.Diabet.Stud_6_247 |
| PubMedID: 20043037 |
| Title : Saxagliptin, a dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes - Gallwitz_2008_IDrugs_11_906 |
| Author(s) : Gallwitz B |
| Ref : IDrugs , 11 :906 , 2008 |
| Abstract : |
| PubMedSearch : Gallwitz_2008_IDrugs_11_906 |
| PubMedID: 19051153 |
| Title : Saxagliptin, a dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes - Gallwitz_2008_IDrugs_11_906 |
| Author(s) : Gallwitz B |
| Ref : IDrugs , 11 :906 , 2008 |
| Abstract : |
| PubMedSearch : Gallwitz_2008_IDrugs_11_906 |
| PubMedID: 19051153 |
| Title : Saxagliptin, a dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes - Gallwitz_2008_IDrugs_11_906 |
| Author(s) : Gallwitz B |
| Ref : IDrugs , 11 :906 , 2008 |
| Abstract : |
| PubMedSearch : Gallwitz_2008_IDrugs_11_906 |
| PubMedID: 19051153 |
| Title : Sitagliptin: Profile of a novel DPP-4 inhibitor for the treatment of type 2 diabetes - Gallwitz_2007_Drugs.Today.(Barc)_43_13 |
| Author(s) : Gallwitz B |
| Ref : Drugs Today (Barc) , 43 :13 , 2007 |
| Abstract : |
| PubMedSearch : Gallwitz_2007_Drugs.Today.(Barc)_43_13 |
| PubMedID: 17315049 |
| Title : Sitagliptin with metformin: profile of a combination for the treatment of type 2 diabetes - Gallwitz_2007_Drugs.Today.(Barc)_43_681 |
| Author(s) : Gallwitz B |
| Ref : Drugs Today (Barc) , 43 :681 , 2007 |
| Abstract : |
| PubMedSearch : Gallwitz_2007_Drugs.Today.(Barc)_43_681 |
| PubMedID: 17987221 |
| Title : Sitagliptin: profile of a novel DPP-4 inhibitor for the treatment of type 2 diabetes (update) - Gallwitz_2007_Drugs.Today.(Barc)_43_801 |
| Author(s) : Gallwitz B |
| Ref : Drugs Today (Barc) , 43 :801 , 2007 |
| Abstract : |
| PubMedSearch : Gallwitz_2007_Drugs.Today.(Barc)_43_801 |
| PubMedID: 18174966 |
| Title : Sitagliptin: Profile of a novel DPP-4 inhibitor for the treatment of type 2 diabetes - Gallwitz_2007_Drugs.Today.(Barc)_43_13 |
| Author(s) : Gallwitz B |
| Ref : Drugs Today (Barc) , 43 :13 , 2007 |
| Abstract : |
| PubMedSearch : Gallwitz_2007_Drugs.Today.(Barc)_43_13 |
| PubMedID: 17315049 |
| Title : Sitagliptin with metformin: profile of a combination for the treatment of type 2 diabetes - Gallwitz_2007_Drugs.Today.(Barc)_43_681 |
| Author(s) : Gallwitz B |
| Ref : Drugs Today (Barc) , 43 :681 , 2007 |
| Abstract : |
| PubMedSearch : Gallwitz_2007_Drugs.Today.(Barc)_43_681 |
| PubMedID: 17987221 |
| Title : Sitagliptin: profile of a novel DPP-4 inhibitor for the treatment of type 2 diabetes (update) - Gallwitz_2007_Drugs.Today.(Barc)_43_801 |
| Author(s) : Gallwitz B |
| Ref : Drugs Today (Barc) , 43 :801 , 2007 |
| Abstract : |
| PubMedSearch : Gallwitz_2007_Drugs.Today.(Barc)_43_801 |
| PubMedID: 18174966 |
| Title : Sitagliptin: Profile of a novel DPP-4 inhibitor for the treatment of type 2 diabetes - Gallwitz_2007_Drugs.Today.(Barc)_43_13 |
| Author(s) : Gallwitz B |
| Ref : Drugs Today (Barc) , 43 :13 , 2007 |
| Abstract : |
| PubMedSearch : Gallwitz_2007_Drugs.Today.(Barc)_43_13 |
| PubMedID: 17315049 |
| Title : Sitagliptin with metformin: profile of a combination for the treatment of type 2 diabetes - Gallwitz_2007_Drugs.Today.(Barc)_43_681 |
| Author(s) : Gallwitz B |
| Ref : Drugs Today (Barc) , 43 :681 , 2007 |
| Abstract : |
| PubMedSearch : Gallwitz_2007_Drugs.Today.(Barc)_43_681 |
| PubMedID: 17987221 |
| Title : Sitagliptin: profile of a novel DPP-4 inhibitor for the treatment of type 2 diabetes (update) - Gallwitz_2007_Drugs.Today.(Barc)_43_801 |
| Author(s) : Gallwitz B |
| Ref : Drugs Today (Barc) , 43 :801 , 2007 |
| Abstract : |
| PubMedSearch : Gallwitz_2007_Drugs.Today.(Barc)_43_801 |
| PubMedID: 18174966 |
| Title : The glucagon-like peptide-1 metabolite GLP-1-(9-36) amide reduces postprandial glycemia independently of gastric emptying and insulin secretion in humans - Meier_2006_Am.J.Physiol.Endocrinol.Metab_290_E1118 |
| Author(s) : Meier JJ , Gethmann A , Nauck MA , Gotze O , Schmitz F , Deacon CF , Gallwitz B , Schmidt WE , Holst JJ |
| Ref : American Journal of Physiology Endocrinol Metab , 290 :E1118 , 2006 |
| Abstract : |
| PubMedSearch : Meier_2006_Am.J.Physiol.Endocrinol.Metab_290_E1118 |
| PubMedID: 16403774 |
| Title : The glucagon-like peptide-1 metabolite GLP-1-(9-36) amide reduces postprandial glycemia independently of gastric emptying and insulin secretion in humans - Meier_2006_Am.J.Physiol.Endocrinol.Metab_290_E1118 |
| Author(s) : Meier JJ , Gethmann A , Nauck MA , Gotze O , Schmitz F , Deacon CF , Gallwitz B , Schmidt WE , Holst JJ |
| Ref : American Journal of Physiology Endocrinol Metab , 290 :E1118 , 2006 |
| Abstract : |
| PubMedSearch : Meier_2006_Am.J.Physiol.Endocrinol.Metab_290_E1118 |
| PubMedID: 16403774 |
| Title : The glucagon-like peptide-1 metabolite GLP-1-(9-36) amide reduces postprandial glycemia independently of gastric emptying and insulin secretion in humans - Meier_2006_Am.J.Physiol.Endocrinol.Metab_290_E1118 |
| Author(s) : Meier JJ , Gethmann A , Nauck MA , Gotze O , Schmitz F , Deacon CF , Gallwitz B , Schmidt WE , Holst JJ |
| Ref : American Journal of Physiology Endocrinol Metab , 290 :E1118 , 2006 |
| Abstract : |
| PubMedSearch : Meier_2006_Am.J.Physiol.Endocrinol.Metab_290_E1118 |
| PubMedID: 16403774 |
| Title : Glucagon-like peptide-1-based therapies for the treatment of type 2 diabetes mellitus - Gallwitz_2005_Treat.Endocrinol_4_361 |
| Author(s) : Gallwitz B |
| Ref : Treat Endocrinol , 4 :361 , 2005 |
| Abstract : |
| PubMedSearch : Gallwitz_2005_Treat.Endocrinol_4_361 |
| PubMedID: 16318402 |
| Title : New therapeutic strategies for the treatment of type 2 diabetes mellitus based on incretins - Gallwitz_2005_Rev.Diabet.Stud_2_61 |
| Author(s) : Gallwitz B |
| Ref : Rev Diabet Stud , 2 :61 , 2005 |
| Abstract : |
| PubMedSearch : Gallwitz_2005_Rev.Diabet.Stud_2_61 |
| PubMedID: 17491680 |
| Title : Glucagon-like peptide-1-based therapies for the treatment of type 2 diabetes mellitus - Gallwitz_2005_Treat.Endocrinol_4_361 |
| Author(s) : Gallwitz B |
| Ref : Treat Endocrinol , 4 :361 , 2005 |
| Abstract : |
| PubMedSearch : Gallwitz_2005_Treat.Endocrinol_4_361 |
| PubMedID: 16318402 |
| Title : New therapeutic strategies for the treatment of type 2 diabetes mellitus based on incretins - Gallwitz_2005_Rev.Diabet.Stud_2_61 |
| Author(s) : Gallwitz B |
| Ref : Rev Diabet Stud , 2 :61 , 2005 |
| Abstract : |
| PubMedSearch : Gallwitz_2005_Rev.Diabet.Stud_2_61 |
| PubMedID: 17491680 |
| Title : Glucagon-like peptide-1-based therapies for the treatment of type 2 diabetes mellitus - Gallwitz_2005_Treat.Endocrinol_4_361 |
| Author(s) : Gallwitz B |
| Ref : Treat Endocrinol , 4 :361 , 2005 |
| Abstract : |
| PubMedSearch : Gallwitz_2005_Treat.Endocrinol_4_361 |
| PubMedID: 16318402 |
| Title : New therapeutic strategies for the treatment of type 2 diabetes mellitus based on incretins - Gallwitz_2005_Rev.Diabet.Stud_2_61 |
| Author(s) : Gallwitz B |
| Ref : Rev Diabet Stud , 2 :61 , 2005 |
| Abstract : |
| PubMedSearch : Gallwitz_2005_Rev.Diabet.Stud_2_61 |
| PubMedID: 17491680 |
| Title : Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum - Mentlein_1993_Eur.J.Biochem_214_829 |
| Author(s) : Mentlein R , Gallwitz B , Schmidt WE |
| Ref : European Journal of Biochemistry , 214 :829 , 1993 |
| Abstract : |
| PubMedSearch : Mentlein_1993_Eur.J.Biochem_214_829 |
| PubMedID: 8100523 |
| Title : Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum - Mentlein_1993_Eur.J.Biochem_214_829 |
| Author(s) : Mentlein R , Gallwitz B , Schmidt WE |
| Ref : European Journal of Biochemistry , 214 :829 , 1993 |
| Abstract : |
| PubMedSearch : Mentlein_1993_Eur.J.Biochem_214_829 |
| PubMedID: 8100523 |
| Title : Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum - Mentlein_1993_Eur.J.Biochem_214_829 |
| Author(s) : Mentlein R , Gallwitz B , Schmidt WE |
| Ref : European Journal of Biochemistry , 214 :829 , 1993 |
| Abstract : |
| PubMedSearch : Mentlein_1993_Eur.J.Biochem_214_829 |
| PubMedID: 8100523 |